Expert Interview
Discussing the results published by JAMA Neurology on the Positive Phase 3 Study of REXULTI® (brexpiprazole) for agitation associated with Dementia due to Alzheimer’s Disease
Ticker(s): OTSKYInstitution: Private Practice, San Antonio
- Private practice physician in San Antonio with experience in both psychiatry and neurology.
- Works in an outpatient mental health clinic where he sees a wide range of psychiatric patients from schizophrenia to bipolar as well as substance abuse, anxiety patients and depression patients.
- Currently manages 45 bipolar patients and has treated several of his patients with Caplyta, successfully.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
